Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes: The ADVANCE trial

The optimal blood pressure (BP) goal in patients with diabetes remains controversial. We examined whether benefits and risks of intensified antihypertensive therapy in diabetes are influenced by either baseline BP or cardiovascular disease (CVD) risk. We studied 10,948 people with diabetes, at moder...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hypertension
Päätekijät: Rahman, Faisal, McEvoy, John W., Ohkuma, Toshiaki, Marre, Michel, Hamet, Pavel, Harrap, Stephen, Mancia, Giuseppe, Rodgers, Anthony, Selvin, Elizabeth, Williams, Bryan, Muntner, Paul, Chalmers, John, Woodward, Mark
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506385/
https://ncbi.nlm.nih.gov/pubmed/31030606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12414
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia